Agilent Technologies

A 125.02
2.60 (2.1%)

Open: 122.26 High: 125.41 Low: 122.01

9 x 125.02 = 1125.18
x $125.02 =

NYSE: A $37 Billion Large-Cap. S&P 500. Health Care Sector. Medical Equipment & Devices Industry. 5 Year Return 233%. 1 Year Return 60%. 2021 YTD Return 5%. 0.6% dividend yield. 36 total dividend payments. Since Earnings 2%.

ST

External Links

Charts

image
image

52WL $62.09

The 52 Week Low is $62.09 set on Mon, Mar 23, 2020.

52WH $136.98

The 52 Week High is $136.98 set on Wed, Feb 17, 2021.

ATH $162.00

The All-Time High is $162.00 set on Mon, Mar 6, 2000.

52 Week Range

$62.09
$136.98
Mar 23, 2020
Feb 17, 2021

Earnings

0.94

Earnings Per Share

21.41

Price To Earnings Ratio


Q3 Earnings for Jul, Aug & Sep

Mon, Nov 23, 2020

Since Q3 Earnings Report

A 12.7%


Q4 Earnings for Oct, Nov & Dec

Tue, Feb 16, 2021

Since Q4 Earnings Report

A 2.3%

Dividends

0.62

Dividend Yield

0.78

Dividend Rate

Mon, Jan 4, 2021

Ex-Dividend Date

Wed, Jan 27, 2021

Dividend Payment Date

Quarterly

Dividend Frequency

36

Dividend History

Profile

Agilent Technologies trades on the NYSE. A's market cap is 37.4 Billion.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.